Proquifin S.A. de C.V., Vanda sales and marketing update

Vanda granted Proquifin's Probiomed S.A. de C.V. pharmaceutical operating unit exclusive rights in Mexico to commercialize schizophrenia drug Fanapt iloperidone. Probiomed, which is responsible for gaining regulatory approval in Mexico, plans to submit a marketing application by year end. Details were not disclosed. ...